A Pennsylvania woman who suffered chemo hair loss after being treated with Taxotere has filed a lawsuit, alleging that she was not adequately warned that the condition may be permanent.

This Taxotere lawsuit is one of a slew of chemo hair loss allegations to hit Sanofi Aventis over problems with Taxotere. Lawsuits like this allege that Sanofi failed to adequately warn about the significant risk of permanent chemo hair loss associated with Taxotere.

The plaintiff, Margaret P., is a breast cancer patient who first underwent treatment with Taxotere on June 10, 2008, and continued with regular treatments for several weeks, through Sept. 23, 2008. Although Margaret, like most cancer patients, went into her chemotherapy treatment aware of the risk of chemo hair loss, she was not aware that this chemo hair loss may actually be permanent.

According to the lawsuit, Margaret’s hair has not successfully grown back nearly eight years after her chemo treatment completed. She has been left with permanent chemo hair loss, she alleges, with some patchy hair growth and thin hair.

Margaret filed her chemo hair loss lawsuit on multiple counts, including failure to warn, negligence, fraudulent misrepresentation and concealment, and fraud and deceit.

More and more cancer patients like Margaret are coming forward with allegations of permanent chemo hair loss, or alopecia, after treatment with Taxotere. Others still have difficulty growing their hair back, and it grows instead in patches.

Basics of Taxotere

Taxotere (also known by its generic name, docetaxel) is a popular chemotherapy drug manufactured by pharmaceutical giant Sanofi Aventis. Since Taxotere’s approval by the U.S. Food and Drug Administration (FDA) back in 1996, it has become one of the more well-known chemotherapy drugs. Despite its popularity, Taxotere has been linked with permanent chemo hair loss.

Permanent Chemo Hair Loss from Taxotere

Hair loss is a common symptom associated with chemotherapy treatment. The majority of cancer patients go into chemotherapy treatment aware that they run the risk of losing their hair to alopecia from the treatment. But these patients generally expect that after their chemotherapy treatment is over, their hair will eventually grow back.

Unfortunately, a growing number of cancer patients like Margaret are finding that this may not be the case, and have been left with permanent chemo hair loss. Some are unable to grow their hair back at all, and others can only do so with great difficulty, able to grow it in clumps or patches.

Filing a Taxotere Lawsuit Over Permanent Chemo Hair Loss

If you or someone you love has suffered from permanent chemo hair loss or another docetaxel medication, you may be able to seek financial compensation by joining a Taxotere lawsuit.

Filing a Taxotere chemo hair loss lawsuit cannot take away the pain and suffering a cancer patient endures, or take away the effects of permanent hair loss, but it can help compensate for the financial expenses incurred by cancer treatment bills or even lost wages.

This Chemo Hair Loss Lawsuit is Case No. 2:17-cv-17457, in the U.S. District Court for the Eastern District of Louisiana.